TNGX Q3'26 Earnings: revenue estimate is 0 USD
Meno di 1 minuto di lettura
TNGX (Tango Therapeutics, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).
For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.35) USD. Learn more details at TNGX Financials page.
Revenue & EPS values are provided in USD
| Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | |
|---|---|---|---|---|---|
| Revenue Reported | 53.81 M | — | — | — | — |
| Revenue Estimate | 53.80 M | 500.40 K | 578.09 K | — | — |
| Revenue Surprise | +0.02% | -100.00% | -100.00% | ||
| EPS Reported | 0.14 | (0.29) | (0.32) | (0.37) | |
| EPS Estimate | (0.05) | (0.32) | (0.31) | (0.32) | (0.35) |
| EPS Surprise | +376.92% | +8.86% | -2.01% | -16.64% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.